January 2026 in “Animals” TBX3 gene affects pigmentation and marking formation in Dun Mongolian horses.
August 2025 in “Journal of Cosmetic Dermatology” The dietary supplement AGA-P improves the effectiveness of hair loss treatments.
July 2025 in “Pakistan Journal of Medicine and Dentistry” Smoking increases the risk and severity of male pattern baldness.
April 2025 in “International Journal of Research in Dermatology” Combining Ayurvedic therapies with minoxidil is more effective for hair growth in men than using minoxidil alone.
March 2025 in “Chinese Medical Journal” Topical finasteride effectively and safely increases hair growth in men with hair loss.
March 2025 in “Journal of Cutaneous and Aesthetic Surgery” The cytokine and peptide serum was most effective in reducing hair loss and improving hair growth.
February 2025 in “BMC Public Health” Unhealthy diet and lifestyle choices may increase the risk of hair loss in women.
January 2025 in “Skin Appendage Disorders” Low-dose oral minoxidil does not significantly change alcohol consumption.
January 2025 in “International Journal of Clinical and Diagnostic Pathology” Most skin adnexal tumors are benign and require histopathological examination for accurate diagnosis.
December 2024 in “Food Bioscience” Limosilactobacillus fermentum MF10 helps hair grow by activating certain cell signals in mice.
October 2024 in “Asian Journal of Pharmaceutical and Clinical Research” Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.
The new gel for hair loss is safe, effective, and reduces side effects.
April 2024 in “Journal of dermatology research reviews & reports” Using a laser helmet with Minoxidil works better for male hair loss than Minoxidil alone, with no extra side effects.
Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.
November 2023 in “BMC genomics” The study concluded that the arachidonic acid pathway and the protein KRT79 play a role in determining the fineness of cashmere.
July 2023 in “Journal of the ASEAN Federation of Endocrine Societies” GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.
January 2023 in “International Journal of Dermatology and Venereology” Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.
Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.
Topical latanoprost acid at 0.05% concentration improved hair growth in women with androgenetic alopecia.
March 2026 in “Critical Care Medicine” Hair restoration can cause severe seizures due to combined drug toxicity.
February 2026 in “British Journal of Sports Medicine” Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.
December 2025 in “Obesity Surgery” One-anastomosis gastric bypass leads to lower zinc levels and more symptoms than sleeve gastrectomy.
September 2025 in “International Journal of Scientific Research” PRP is more effective than Minoxidil for treating male pattern baldness.
July 2025 in “Agroindustrial Technology Journal” The 2% rosemary oil shampoo was the best overall.
June 2025 in “British Journal of Dermatology” Standardized forms and digital tools can improve alopecia biopsy diagnosis.
June 2025 in “Journal of Cosmetic Dermatology” Botanical extract shampoo and tonic improved hair loss in most participants.
May 2025 in “Actas Dermo-Sifiliográficas” Botulinum toxin is not effective for treating androgenetic alopecia.
October 2024 in “Photodermatology Photoimmunology & Photomedicine” Red LED therapy is more effective than green LED for improving hair growth in androgenetic alopecia.
August 2024 in “Journal of Cosmetic Dermatology” CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.
July 2024 in “Journal of Investigative Dermatology” 5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.